Finder makes money from featured partners, but editorial opinions are our own. Advertiser disclosure

How to buy Intellia Therapeutics stock

Learn how to easily invest in Intellia Therapeutics stock.

Intellia Therapeutics is a biotechnology business based in the US. Intellia Therapeutics shares (NTLA) are listed on the NASDAQ and all prices are listed in US Dollars. Intellia Therapeutics employs 598 staff and has a trailing 12-month revenue of around $53 million.

How to buy Intellia Therapeutics stock

  1. Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – NTLA. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Promoted for low fees

Finder Award

SoFi Invest

  • Trade stocks for $0 and no annual fee
  • Start trading with a $0 minimum deposit
  • Get up to $1,000 in stock when you fund a new account within 30 days

Promoted for social trading

Finder Award


  • Easy to use platform with $0 stock trading & no annual fees
  • Social trading allows you to copy popular portfolios
  • FINDER EXCLUSIVE: Guaranteed $15 bonus when you sign up and deposit $100

Promoted for active trading


  • $0 commissions on stocks and ETFs
  • $0 closing commissions on stock and ETF options
  • Get $100 - $2,000 when you open and fund an account with $5,000 to $100,000+

Intellia Therapeutics stock price (NASDAQ: NTLA)

Use our graph to track the performance of NTLA stocks over time.

Intellia Therapeutics shares at a glance

Information last updated 2023-09-19.
Latest market close$33.53
52-week range$32.44 - $63.12
50-day moving average $39.80
200-day moving average $39.71
Wall St. target price$83.71
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-5.42

Buy Intellia Therapeutics stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.
1 - 7 of 7
Name Product Ratings Available asset types Minimum deposit Signup bonus
SoFi Invest
Finder Rating: 4.6 / 5: ★★★★★

Finder Award
SoFi Invest
Stocks, Options, ETFs, Cryptocurrency
Get up to $1,000 in stock
when you fund a new account within 30 days.
Winner of Finder’s Best Low-Cost Broker award.
Finder Rating: 4.2 / 5: ★★★★★

Finder Award
Stocks, Options, ETFs, Cryptocurrency
FINDER EXCLUSIVE: Get a guaranteed $15 bonus
when you sign up and deposit $100
Winner of Finder’s Best Broker for Beginners award. Not available in NY, NV, MN, TN, and HI.
Finder Rating: 4.1 / 5: ★★★★★
Stocks, Options, ETFs, Cryptocurrency, Futures
Get $100 - $2,000
when you you open and fund an account with $5,000 to $100,000+
Highly commended for Best Derivatives Trading Platform award.
Finder Rating: 4 / 5: ★★★★★
Stocks, ETFs, Cryptocurrency, Art, Treasury Bills, Collectibles
Get up to $300 in either stocks or crypto
when you use code FINDERUS to sign up and fund a new account.
2.5% fee applies to all alternative asset transactions.
Finder Rating: 4.2 / 5: ★★★★★
Stocks, Options, ETFs, Cryptocurrency
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 4.9% interest on uninvested cash in your account with Robinhood Gold.
JPMorgan Self-Directed Investing
Finder Rating: 4 / 5: ★★★★★
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs, Treasury Bills
Get $50 - $700
when you open and fund an account with $5,000 - $250,000+
Pay no commissions on stocks, ETFs, mutual funds and options.
Finder Rating: 4 / 5: ★★★★★
Stocks, ETFs
Wealthfront builds a free financial plan for the life you want and automate your investments at a low cost.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an adviser or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Is it a good time to buy Intellia Therapeutics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Intellia Therapeutics price performance over time

Historical closes compared with the close of $33.53 from 2023-09-21

1 week (2023-09-15) -6.39%
1 month (2023-08-23) -12.57%
3 months (2023-06-23) -18.18%
6 months (2023-03-23) -9.82%
1 year (2022-09-23) -37.82%
2 years (2021-09-23) -78.40%
3 years (2020-09-23) 59.06%
5 years (2018-09-21) 25.21%

Intellia Therapeutics financials

Revenue TTM $53 million
Gross profit TTM $-367,858,000
Return on assets TTM -23.62%
Return on equity TTM -45.68%
Profit margin 0%
Book value $12.51
Market Capitalization $3.1 billion

TTM: trailing 12 months

Intellia Therapeutics share dividends

We're not expecting Intellia Therapeutics to pay a dividend over the next 12 months.

Intellia Therapeutics share price volatility

Over the last 12 months, Intellia Therapeutics's shares have ranged in value from as little as $32.435 up to $63.12. A popular way to gauge a stock's volatility is its "beta".

NTLA.US volatility(beta: 1.84)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Intellia Therapeutics's is 1.8361. This would suggest that Intellia Therapeutics's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Intellia Therapeutics overview

Intellia Therapeutics, Inc. , a genome editing company, focuses on the development of curative therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as for other product candidates, including NTLA-2003 for alpha-1 antitrypsin deficiency-liver disease; and NTLA-3001 for alpha-1 antitrypsin deficiency-lung disease; and NTLA-6001 for CD30+ lymphomas. It also focus on programs comprising hemophilia A and hemophilia B; ex vivo pipeline including NTLA-5001 for the treatment of acute myeloid leukemia; and proprietary programs focused on developing engineered cell therapies to treat various cancers and autoimmune diseases. In addition, it offers tools comprising of Clustered, Regularly Interspaced Short Palindromic Repeats/CRISPR associated 9 (CRISPR/Cas9) system. Further, the company has license and collaboration agreement with Regeneron Pharmaceuticals, Inc. to co-develop potential products for the treatment of hemophilia A and hemophilia B; and AvenCell Therapeutics, Inc.

Frequently asked questions

What percentage of Intellia Therapeutics is owned by insiders or institutions?
Currently 5.343% of Intellia Therapeutics shares are held by insiders and 87.898% by institutions.
How many people work for Intellia Therapeutics?
Latest data suggests 598 work at Intellia Therapeutics.
When does the fiscal year end for Intellia Therapeutics?
Intellia Therapeutics's fiscal year ends in December.
Where is Intellia Therapeutics based?
Intellia Therapeutics's address is: 40 Erie Street, Cambridge, MA, United States, 02139
What is Intellia Therapeutics's ISIN number?
Intellia Therapeutics's international securities identification number is: US45826J1051
What is Intellia Therapeutics's CUSIP number?
Intellia Therapeutics's Committee on Uniform Securities Identification Procedures number is: 45826J105

More guides on Finder

Ask an Expert provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Go to site